Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Singular Genomics Systems Inc

OMIC
Current price
20.01 USD 0 USD (0.00%)
Last closed 20.01 USD
ISIN US82933R1005
Sector Healthcare
Industry Medical Instruments & Supplies
Exchange NASDAQ
Capitalization 50 765 772 USD
Yield for 12 month +66.75 %
1Y
3Y
5Y
10Y
15Y
OMIC
21.11.2021 - 28.11.2021

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private. Address: 3010 Science Park Road, San Diego, CA, United States, 92121

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

12.45 USD

P/E ratio

Dividend Yield

Current Year

+2 911 000 USD

Last Year

+765 000 USD

Current Quarter

+406 000 USD

Last Quarter

+737 000 USD

Current Year

-558 000 USD

Last Year

-24 000 USD

Current Quarter

-301 000 USD

Last Quarter

-178 000 USD

Key Figures OMIC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -87 093 000 USD
Operating Margin TTM -4 450.99 %
Price to Earnings
Return On Assets TTM -24.21 %
PEG Ratio
Return On Equity TTM -53.57 %
Wall Street Target Price 12.45 USD
Revenue TTM 2 667 000 USD
Book Value 49.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -12.10 %
Dividend Yield
Gross Profit TTM -1 354 000 USD
Earnings per share -34.68 USD
Diluted Eps TTM -34.68 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics OMIC

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History OMIC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor 1:30
Payout Ratio
Last Split Date 26.06.2024

Stock Valuation OMIC

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM 19.03
Enterprise Value EBITDA 0.77
Price Book MRQ 0.41

Financials OMIC

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators OMIC

For 52 weeks

5.34 USD 23.41 USD
50 Day MA 19.77 USD
Shares Short Prior Month 45 429
200 Day MA 14.35 USD
Short Ratio 4.34
Shares Short 44 745
Short Percent 2.47 %